GB1157100A - Pharmaceutical Compositions - Google Patents

Pharmaceutical Compositions

Info

Publication number
GB1157100A
GB1157100A GB43132/66A GB4313266A GB1157100A GB 1157100 A GB1157100 A GB 1157100A GB 43132/66 A GB43132/66 A GB 43132/66A GB 4313266 A GB4313266 A GB 4313266A GB 1157100 A GB1157100 A GB 1157100A
Authority
GB
United Kingdom
Prior art keywords
mycophenolic acid
pharmaceutical compositions
haldane
soft paraffin
emulsion base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB43132/66A
Inventor
Stephen Barnaby Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB43132/66A priority Critical patent/GB1157100A/en
Priority to CA998,195A priority patent/CA1016459A/en
Priority to DE19671617547 priority patent/DE1617547A1/en
Priority to NL6712392A priority patent/NL6712392A/xx
Priority to BE704326D priority patent/BE704326A/xx
Priority to FR122314A priority patent/FR7541M/fr
Publication of GB1157100A publication Critical patent/GB1157100A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,157,100. Compositions comprising mycophenolic acid. IMPERIAL CHEMICAL INDUSTRIES Ltd. 2 Aug., 1967 [27 Sept., 1966], No. 43132/66. Heading A5B. Pharmaceutical compositions comprise mycophenolic acid of the formula: or a 'salt or alkyl ester thereof wherein the alkyl radical is of not more than six carbon atoms, and an inert, non toxic, pharmaceutically acceptable diluent or carrier but excluding a non-sterile solution of mycophenolic acid or a sodium or potassium salt thereof in water and an ointment consisting of mycophenolic acid in soft paraffin or in Haldane's emulsion base, or in a mixture of equal parts of soft paraffin and Haldane's emulsion base.
GB43132/66A 1966-09-27 1966-09-27 Pharmaceutical Compositions Expired GB1157100A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB43132/66A GB1157100A (en) 1966-09-27 1966-09-27 Pharmaceutical Compositions
CA998,195A CA1016459A (en) 1966-09-27 1967-08-18 Pharmaceutical compositions containing mycophenolic acid and its salts
DE19671617547 DE1617547A1 (en) 1966-09-27 1967-09-08 Pharmaceutical mass
NL6712392A NL6712392A (en) 1966-09-27 1967-09-08
BE704326D BE704326A (en) 1966-09-27 1967-09-26
FR122314A FR7541M (en) 1966-09-27 1968-12-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43132/66A GB1157100A (en) 1966-09-27 1966-09-27 Pharmaceutical Compositions

Publications (1)

Publication Number Publication Date
GB1157100A true GB1157100A (en) 1969-07-02

Family

ID=10427451

Family Applications (1)

Application Number Title Priority Date Filing Date
GB43132/66A Expired GB1157100A (en) 1966-09-27 1966-09-27 Pharmaceutical Compositions

Country Status (6)

Country Link
BE (1) BE704326A (en)
CA (1) CA1016459A (en)
DE (1) DE1617547A1 (en)
FR (1) FR7541M (en)
GB (1) GB1157100A (en)
NL (1) NL6712392A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4868153A (en) * 1987-01-30 1989-09-19 Syntex (U.S.A.) Inc. Treatment of allograft rejection with mycophenolic acid, its morpholinoethylester and derivatives thereof
WO1995009626A1 (en) * 1993-10-01 1995-04-13 Syntex (U.S.A.) Inc. Mycophenolate mofetil high dose oral suspensions
US6025391A (en) * 1996-04-12 2000-02-15 Novartis Ag Enteric-coated pharmaceutical compositions of mycophenolate
WO2004087174A1 (en) * 2003-04-01 2004-10-14 Novartis Ag Parenteral formulation of mycophenolic acid, a salt or prodrug thereof
WO2005042507A1 (en) * 2003-11-03 2005-05-12 Biocon Limited Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt
NO341804B1 (en) * 2001-10-17 2018-01-22 Novartis Ag Process for preparing a pharmaceutical composition which includes mycophenolic acid or mycophenolate salt.

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4868153A (en) * 1987-01-30 1989-09-19 Syntex (U.S.A.) Inc. Treatment of allograft rejection with mycophenolic acid, its morpholinoethylester and derivatives thereof
US4948793A (en) * 1987-01-30 1990-08-14 Syntex (U.S.A.) Inc. Treatment of autoimmune diseases with the morpholinoethyl ester of mycophenolic acid, and derivatives thereof
US4952579A (en) * 1987-01-30 1990-08-28 Syntex (U.S.A.) Inc. Method of treating diseases by administering morpholino-ethylester of mycophenolic acid or derivatives thereof
US4992467A (en) * 1987-01-30 1991-02-12 Syntex (U.S.A.) Inc. Treatment of autoimmune diseases with mycophenolic acid, and derivatives and formulations thereof
WO1995009626A1 (en) * 1993-10-01 1995-04-13 Syntex (U.S.A.) Inc. Mycophenolate mofetil high dose oral suspensions
US5688529A (en) * 1993-10-01 1997-11-18 Syntex (U.S.A) Inc. Mycophenolate mofetil high dose oral suspensions
EP1475091A1 (en) * 1993-10-01 2004-11-10 Roche Palo Alto LLC Mycophenolate mofetil - high dose oral suspensions
US6172107B1 (en) 1996-04-12 2001-01-09 Novartis Ag Entric-coated pharmaceutical compositions
US6306900B1 (en) 1996-04-12 2001-10-23 Novartis Ag Enteric coated pharmaceutical compositions
US6025391A (en) * 1996-04-12 2000-02-15 Novartis Ag Enteric-coated pharmaceutical compositions of mycophenolate
RU2615397C2 (en) * 1996-04-12 2017-04-04 Новартис Аг Pharmaceutical enteric coated compositions based on mycophenolic acid salt
NO341804B1 (en) * 2001-10-17 2018-01-22 Novartis Ag Process for preparing a pharmaceutical composition which includes mycophenolic acid or mycophenolate salt.
EP1438040B2 (en) † 2001-10-17 2019-10-16 Novartis AG Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
WO2004087174A1 (en) * 2003-04-01 2004-10-14 Novartis Ag Parenteral formulation of mycophenolic acid, a salt or prodrug thereof
AU2004226807B2 (en) * 2003-04-01 2008-02-21 Novartis Ag Parenteral formulation of mycophenolic acid, a salt or prodrug thereof
CN100427097C (en) * 2003-04-01 2008-10-22 诺瓦提斯公司 Parenteral formulation of mycophenolic acid, a salt or prodrug thereof.
WO2005042507A1 (en) * 2003-11-03 2005-05-12 Biocon Limited Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt

Also Published As

Publication number Publication date
CA1016459A (en) 1977-08-30
NL6712392A (en) 1968-03-28
DE1617547A1 (en) 1970-07-30
FR7541M (en) 1969-12-22
BE704326A (en) 1968-03-26

Similar Documents

Publication Publication Date Title
GB1323553A (en) Thiophene derivatives
ES8505650A1 (en) Fat emulsion containing prostaglandin.
GB1157100A (en) Pharmaceutical Compositions
GB1271466A (en) Thiocarbamic acid derivatives
GB1296544A (en)
GB1141936A (en) Improvements in or relating to benzimidazole derivatives
GB1171670A (en) Derivatives of 4-Aryl-3-Hydroxybutyric Acid
GB1097531A (en) Improvements in or relating to the preparation of cyclopentane derivatives
GB1255098A (en) Derivatives of glycyrrhetinic acid
GB1347598A (en) Lincomycin derivatives and the manufacture thereof
GB1382787A (en) Aryl-piperazine derivatives of adenine
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof
GB1368680A (en) Adriamycin derivatives
GB1437788A (en) Therapeutic compositions
GB1098983A (en) Isoxazole compounds, their non-toxic salts, and the preparation thereof
ES481271A1 (en) Derivatives of L-cysteine, their use as medicaments and process for their preparation.
GB1350133A (en) Thiophosphoroamidates
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
GB1479419A (en) Phenoxyalkanecarboxylic acid derivatives
GB1256984A (en)
GB1058468A (en) Improvements in or relating to (2-amino-1-hydroxyethyl)-thianaphthenes
SE7415495L (en)
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones
GB1456343A (en) N4-acylarabinonucleosides apparatus for handling articles
GB1342643A (en) Thioacetanilide derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLE Entries relating assignments, transmissions, licences in the register of patents